Diaceutics, London Genetics to Co-Develop Software to Support Biomarker Research Collaborations
September 15, 2010
Diaceutics, London Genetics to Co-Develop Software to Support Biomarker Research Collaborations
The new software, which the firms plan to launch next year, is based on the Diaceutics Fusion platform, a personalized medicine planning application designed for targeted therapy development teams, and the London Genetics Biomarker Pathway platform.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Diaceutics, London Genetics to Develop Informatics Solution for Biomarker Research
September 17, 2010 / BioInform - Roswell Park Launches New Center for Personalized Medicine
February 1, 2013 / GenomeWeb Daily News - Study Shows Aspirin Could Increase Survival in Colorectal Cancer Patients with PIK3CA Mutations
November 28, 2012 / Pharmacogenomics Reporter - MSU to Use $1.5M Award to Study Spread of HER2 Breast Cancers
September 21, 2012 / GenomeWeb Daily News - Medical Education Firm Launches Online Tool to Help Docs Guide Personalized Rx Decisions in NSCLC
September 12, 2012 / Pharmacogenomics Reporter